Philipp Hoffmann, based in Munich, Bavaria, Germany, is currently a Executive Director, Head Business Development & Licensing at Daiichi Sankyo Europe GmbH, bringing experience from previous roles at Daiichi Sankyo Europe GmbH, MorphoSys AG and Xerion Pharmaceuticals AG. Philipp Hoffmann holds a 1995 - 1999 PhD in Biology @ University of Hamburg. With a robust skill set that includes Biotechnology, Pharmaceutical Industry, Biopharmaceuticals, Monoclonal Antibodies, In-licensing and more, Philipp Hoffmann contributes valuable insights to the industry. Philipp Hoffmann has 2 emails on RocketReach.